Fig. 4.
Fig. 4. Lysis of HA-1+ or HA-2+leukemic cells by ex vivo–induced HA-1– and HA-2–specific CTLs. Data are representative for all ex vivo–induced CTLs. The lysis of same target cells by in vivo–induced HA-1– and HA-2–specific CTLs, and by control HLA-A*0201–specific CTL clone are shown for comparison. Target cells: HA-1− or HA-2− EBV-LCL (△); HA-1+ or HA-2+ EBV-LCL (▧); leukemic cells positive for HA-1 (n = 4) or HA-2 (n = 3) (⧫); HA-1+ or HA-2+ leukemic cells cultured with IFN-γ + TNF- (◍).

Lysis of HA-1+ or HA-2+leukemic cells by ex vivo–induced HA-1– and HA-2–specific CTLs. Data are representative for all ex vivo–induced CTLs. The lysis of same target cells by in vivo–induced HA-1– and HA-2–specific CTLs, and by control HLA-A*0201–specific CTL clone are shown for comparison. Target cells: HA-1 or HA-2 EBV-LCL (△); HA-1+ or HA-2+ EBV-LCL (▧); leukemic cells positive for HA-1 (n = 4) or HA-2 (n = 3) (⧫); HA-1+ or HA-2+ leukemic cells cultured with IFN-γ + TNF- (◍).

Close Modal

or Create an Account

Close Modal
Close Modal